Skip to main content
PLOS One logoLink to PLOS One
. 2025 Aug 21;20(8):e0328515. doi: 10.1371/journal.pone.0328515

Syndemic interactions between HIV/AIDS, mental health conditions, and non-communicable diseases in sub-Saharan Africa: A scoping review of contributing factors

Arvin B Karbasi 1,*,#, Chukwuemeka Iloegbu 1,#, Christina Ruan 1,#, Nana Osei-Tutu 1, Kahini Patel 1, Leah Frerichs 1, John Patena 1, Dorice Vieira 1, Deborah Adenikinju 1, Lydia Samuels 1, Joyce Gyamfi 1, Emmanuel Peprah 1
Editor: Saima Hirani2
PMCID: PMC12370135  PMID: 40839573

Abstract

Introduction

The syndemic framework provides a critical lens for understanding the complex interplay between HIV/AIDS, mental health (MH) conditions, and non-communicable diseases (NCDs) in Africa. This scoping review explores how these conditions converge to form a syndemic that disproportionately affects vulnerable populations – particularly people living with HIV/AIDS (PLWH). Contextual factors such as stigma, lower socioeconomic resulting in poverty, gender, resource limitations, and fragmented healthcare systems exacerbate these interrelated conditions, posing significant challenges to individuals and their health.

Methods

A scoping review was conducted to examine the syndemic interactions between HIV/AIDS, MH, and NCDs across Africa. Utilizing the PRISMA-ScR framework and a predefined inclusion criterion, literature searches were conducted in the following databases: PubMed/Medline (OVID), Web of Science (all databases), Web of Science (core collection), Global Health, Cumulative Index of Allied Health Literature (CINAHL), MEDLINE OVID, Psychinfo (OVID), Psychinfo (proquest); and Psychinfo (psychnet) in March 2024. Articles were screened independently by two peer reviewers and conflicts were resolved by a third reviewer. Data were extracted to summarize study characteristics, prevalence rates, and the contextual factors that underpin syndemic interactions among HIV/AIDS, MH and NCDs.

Results

An initial search retrieved 5937 articles, with 2913 articles remaining after removal of duplicates. Title and abstract screening further excluded 2706 articles. In total, 207 full-text articles were assessed, of which 17 publications were extracted and included in the review. The scoping review identified a significant prevalence of multi-morbidities amongst PLWH, particularly within hypertension, diabetes, and depression. Women and older adults were disproportionately affected, with gender and age disparities shaping health outcomes. Contextual factors such as stigma, socioeconomic barriers, and fragmented healthcare systems were consistently reported as key contributors to worsening such multi-morbidities. In many publications, NCDs and MH conditions were undiagnosed or poorly managed, complicating HIV treatment and reducing the quality of life. Individual and structural resource limitations, along with poor healthcare integration, further hindered effective care.

Conclusion

This scoping review underscores the urgent need for integrated healthcare models to address the syndemic of HIV/AIDS, NCDs, and MH in Africa. Interventions should prioritize stigma reduction, capacity building, and comprehensive care to address the underlying socioeconomic determinants of health among PLWH. Strengthening healthcare systems and promoting holistic, patient-centered care is essential for reducing disparities, improving health outcomes, and achieving the Sustainable Development Goals. Future research should expand geographic and demographic coverage to capture the full scope of these syndemic relationships in diverse African contexts.

1. Introduction

The syndemic theory provides a distinct lens that emphasizes the role of local sociocultural, economic, and healthcare infrastructures in shaping the interactions between multiple health conditions [15]. Findings from the literature have discussed the interrelatedness and common underpinnings of multiple overlapping disease burdens with social factors in affected individuals, especially in the presence of limited resources, socioeconomic disparities, or weak health systems [6]. Hence syndemics emphasizes the interconnectedness of diseases that interact synergistically within a given geographical location and identifies the contextual factors that contribute to the clustering of these conditions [2] (Fig 1). The syndemic framework allows us to understand and address complex health challenges within populations. In Africa, the convergence of mental health conditions (MH), Human Immunodeficiency Virus (HIV/AIDS), and non-communicable diseases (NCDs) represents a significant and growing public health challenge that remains largely underexplored through a syndemic lens [7,8]. This multifaceted issue is marked by the rising prevalence of NCDs and MH disorders amongst people living with HIV (PLWH) [9]. The impact of syndemic conditions on fragile healthcare systems is substantial, complicating individual quality of life and straining healthcare resources in low- and middle-income countries (LMICs) [10,11].

Fig 1. Syndemic coupling occurs when the progression of diseases such as NCDs, MH disorders, and HIV/AIDS interaction with broader social and structural vulnerabilities, forming a coupled ecosystem that can either exacerbate or mitigate disease outcomes.

Fig 1

Vulnerability processes (represented by the blue arrows), including stigma, poverty, inadequate healthcare infrastructure, interact to reinforce barriers to health and wellbeing. These vulnerabilities can ultimately hinder access to care. The disease process (represented by the red arrows) shows how the progression of HIV, NCDs, and MH disorders can intertwine, intensifying the impact of each condition. Together, the disease and vulnerability process co-occur, creating a dynamic feedback loop that shapes health outcomes through syndemic coupling (shown by the gray arrows).

The HIV/AIDS epidemic continues to pose a major public health challenge in many African nations, where 25.6 million PLWH and other infectious diseases are on the rise [12,13]. Despite significant progress in the rollout of antiretroviral therapy (ART), stigma, poverty, limited access to healthcare, and challenges with the dissemination of therapies persist as major barriers to improving prevention and treatment efforts [14]. Poverty, for example, is a catalyzing factor for food insecurity which can interact synergistically with pathological co-morbidities to negatively impact an individual’s health [6]. Depression is the most common MH disorder affecting up to 30% of PLWH [15]. Collectively referred to as common mental disorders (CMDs), depression and anxiety, are highly prevalent among PLWH, negatively affecting their quality of life and adherence to care [16,17]. In Africa, MH remains a neglected public health issue, with some countries still lacking MH services, according to the World Mental Health Atlas [1820]. In countries where services exist, the situation remains dire. While the global average of MH professionals across all disciplines is 9 per 100,000, Africa has only 1.4 professionals per 100,000 people [21]. To reduce such MH challenges, addressing the disparities as it relates to MH professionals in Africa is a point of interest. Similarly, annual mental health outpatient visits in Africa total 94 per 100,000, compared to a global average of 2001 per 100,000 [22]. This situation is only the beginning of a larger issue, while additional challenges exacerbated by high disease prevalence, structural barriers, and individual-level difficulties. Research indicates that the prevalence of MH disorders among PLWH without NCDs is 1.5 to 8 times higher than in the general population worldwide [16,17]. This relationship creates a deleterious cycle, resulting in MH disorders that lead to poorer health outcomes, reduced treatment adherence, and increased comorbidity, further complicating effective responses to the HIV/AIDS epidemic.

Simultaneously, the rising prevalence of NCDs presents new challenges for African nations and poses as a double burden. The World Health Organization (WHO) projects that by 2030, NCDs will account for approximately 44% of all deaths in Africa [23]. NCDs represent the leading cause of death worldwide, killing 41 million people each year—equivalent to 71% of all deaths globally. Among NCDs, the top four causes of significant mortality together account for more than 80% of all premature NCD deaths include cardiovascular diseases (17.9 million deaths annually), cancers (9 million), respiratory diseases (3.9 million), and diabetes (1.6 million) [24]. Moreover, the rising prevalence of NCDs in PLWH adds a dual burden of disease, straining under-resourced healthcare systems within the region, and increases the morbidity and mortality due to the complex interplay between HIV/AIDS, NCDs, and their management [25]. This rise is driven by a combination of factors, including increased life expectancy due to improved ART utilization and adherence, which allows individuals to live longer resulting in age-related health risks [26]. Furthermore, lifestyle modifications and unhealthy habits such as poor diet and physical inactivity, significantly contribute to this trend [2729]. Finally, limited healthcare access and resources (ex. scant health education, inadequately trained health care and service providers) in many African countries complicate the early detection and management of NCDs, as well as worsening health outcomes for PLWH [30]. NCDs are often linked with MH disorder, as individuals with chronic conditions encounter increased risk of developing CMD including depression due to the psychological burden of managing their health [31,32]. The stress of living with an NCD and HIV/AIDS, combined with societal factors like poverty and limited access for MH treatment creates a bidirectional relationship between these interrelated diseases, and continue to exacerbate each other [33,34] (Fig 1).

The sociocultural context in many African countries further intensifies the syndemic nature of these health issues. Stigmatization, lack of access to healthcare, poor socioeconomic status complicated by low health literacy [3538] and fragmented care can discourage individuals from seeking necessary treatment. These barriers not only contribute to the persistence of health disparities but also complicate efforts to implement effective evidence-based interventions (EBIs). Addressing these sociocultural factors is essential for fostering environments where individuals feel empowered to seek care and receive the support necessary for their health conditions. However, the interactions among HIV/AIDS, MH disorders, and NCDs extend beyond individual health; they also carry broader public health implications. Addressing these syndemic relationships is crucial for improving health outcomes and achieving the United Nations’ Sustainable Development Goals (SDGs), particularly Goal 3, which aims to ensure healthy lives and promote well-being for all [39]. Thus, the development of integrated and evidence-based tailored health interventions that account for the interplay of various co-morbid conditions is essential for tackling complex health challenges. Remedies include increasing awareness as well as screening for MH disorders and NCDs simultaneously while increase capacity to ensure that healthcare systems are equipped to address these interconnected conditions.

Assessing the impact of the relationships between HIV/AIDS, MH disorders, and NCDs in Africa is both timely and critical. While previous reviews have examined the prevalence and incidence of each condition alongside HIV/AIDS [17,26,4044], there has been no comprehensive scoping review focused solely on the interconnectedness of HIV/AIDS, MH disorders, and NCDs. The purpose of this scoping review is to highlight the hidden syndemic among these three conditions, illuminating the existing literature and providing evidence to inform development and adaption of future EBIs to comprehensively target these complex interactions. To our knowledge, this is the first scoping review to evaluate the MH disorders and NCD amongst PLWH with a synergistic epidemic lens.

2. Methods

A comprehensive scoping review was conducted to synthesize the existing body of evidence on the syndemic relationship between HIV/AIDS, MH, and NCDs across Africa. This review aimed to deepen the understanding of how MH challenges amongst PLWH exacerbate their vulnerability to developing NCDs, including hypertension, diabetes, cardiovascular diseases, and chronic respiratory diseases. By examining the interplay between these health conditions, the study sought to highlight the complex pathways through which MH disorders contribute to the rising prevalence and severity of NCDs among PLWH. This review was guided by the Preferred Reporting Items for Systematic Review and Meta-Analysis extension for Scoping Reviews (PRISMA-ScR) checklist to ensure a comprehensive appraisal of eligible articles [45]. The PRISMA-ScR checklist is provided in S2 Appendix.

2.1 Inclusion/Exclusion criteria

Publications were included if they met the following criteria: (i) were conducted in a Sub-Saharan African country; (ii) included PLWH, MH, and NCDs of interest (i.e., hypertension, diabetes, cardiovascular diseases, and chronic respiratory diseases); (iii) published in English or had translated versions available for non-English articles; (iv) took place between 2000 and 2023; and (v) addressed individuals with multi-morbidities. No limitations were placed on the study design, article type, or the age and gender of participants included in the studies. Exclusion criteria for studies were: (i) research that excluded PLWH, MH disorders, or NCDs of interest; (ii) did not address multi-morbidities; (iii) focused on the biology and pathophysiology of HIV/AIDS.

2.2 Literature search methods

A comprehensive search strategy was developed to identify literature that met the predefined inclusion criteria. All African countries were included. The literature search was conducted on March 2024. The full search Strategy is provided in S1 Appendix.

The literature search was conducted in the following 10 databases: PubMed/Medline (OVID), Web of Science (all databases), Web of Science (core collection), Global Health, Cumulative Index of Allied Health Literature (CINAHL), PsycINFO (OVID), and PsycINFO (ProQuest). All citations were managed using EndNote 21, a bibliographic management program.

2.3 Assessment

All citations were downloaded to Covidence, a web-based software platform, for screening. Peer-reviewed articles were examined and assessed separately by two individual reviewers to reduce bias. Each reviewer pair screened the same articles independently to determine if the inclusion criteria were met by assessing the title and abstract. Further evaluation was then conducted by assessing the entire article at length. Random assignment was utilized to determine screening of articles and disagreements were resolved by a third party. After confirming that the preselected articles met the entire criteria, a data extraction template was developed in Covidence to extract the data. Information highlighting the syndemic relationship between MH, HIV/AIDS, and NCDs were recorded and downloaded from the Covidence platform to an Excel sheet. Inconsistencies in data were subjected to the judgment of a third independent reviewer. The final articles were ultimately chosen by consensus. Title and abstract screening, assessment, and full extraction were conducted by AK, EI, CR, NOT, DV, LF, JP, KP. Data extraction concluded on September 28th, 2024.

2.4 Extraction

Data were extracted via a mix of qualitative and quantitative synthesis in the following manner: (i) a descriptive table summarizing the included publications, including the study design, objectives, and location; (ii) a table detailing the sociodemographic characteristics of the study participants; and (iii) a report on the contextual factors that facilitate the syndemic relationship, along with public health recommendations. The studies were reviewed to explore the syndemic relationship among PLWH, NCDs, and MH disorders in Africa.

2.5 Quality assessment

The quality assessment (QA) was conducted on all included publications using a modified google form by two independent reviewers. Cross-sectional studies were evaluated based on JBI Critical Appraisal Checklist [46]. Qualitative research were evaluated based on Critical Appraisal Skills Programme (CASP) checklist [47]. Mixed Method studies were evaluated based on the Mixed Methods Appraisal Tool (MMAT) tool [48]. Published reports that did not have a defined critical appraisal tool for their specific design were assessed via the overall quality of the article.

The quality assessment was evaluated in three categories for each appraisal: low risk, high risk, and some concerns. Low risk indicated that the item on the assessment tool was described and/or well accounted for in the study according to the tool’s specifications for determination. High risk indicated that the item of bias was not sufficiently described/and or inadequately accounted for in the study. Unclear/not applicable indicated that there was no information provided in the study to determine if the item of bias was addressed. Data was visualized using robvis visualization tool [49]. All studies were then given an overall assessment on a scale ranging from 1 (poor-quality study and/or study indicates a high risk) to 5 (high-quality study and/or study indicates a low risk).

3. Results

3.1 Study selection

An initial search retrieved 5937 articles, with 2913 articles remaining after removal of duplicates. Screening of title and abstract further excluded 2706 articles. In total, 207 full-text articles were assessed, of which 17 publications were extracted and included in the results [5066]. The screening, elimination process, and reasoning for excluding articles are outlined in the PRISMA chart (Fig 2).

Fig 2. Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) flow diagram.

Fig 2

3.2 Study characteristics

Key study characteristics are summarized in Table 1 and locations of where included studies (n = 17) were conducted are visualized in Fig 3. Nearly one-third of the studies were conducted in South Africa (n = 5, 29%), followed by Tanzania (n = 4, 24%), Zimbabwe (n = 2, 11%), Ghana (n = 1, 6%), Uganda (n = 1, 6%), Cameroon (n = 1, 6%), Rwanda (n = 1, 6%), Malawi (n = 1, 6%), and Kenya (n = 1, 6%). Studies were predominately cross-sectional (n = 7, 41%), followed by qualitative (n = 5, 29%), secondary analysis of cross-sectional data (n= 2, 12%), individual-level and dyadic-level analysis (n= 1, 6%), individual-based multi-disease model (n= 1, 6%), and mixed-methods (n = 1, 6%).

Table 1. Characteristics of Included Literature.

Study ID Age Gender (n) Location Type of NCD Type of MH Contextual Factors
Abdulai, 2022 33-85 Male and Female Ghana CVD, DM Depression SES
FoC
Stigma
LoR
Adedijemi, 2021 NR Women (80) and Men (20) Cameroon Cancer Anxiety Stigma
FoC
LoR
Akugizibwe, 2023 25+ Male (18) and Female (12) Uganda CVD, DM Anxiety Stigma
FoC
Bhana, 2017 18+ Male (324) and Female (994) South Africa CVD, DM Depression FoC
Biraguma, 2018 18-70 Female (513) and Male (281) Rwanda CVD Depression FoC
Calderwood, 2024 18+ Female (5215) and Male (1383) Zimbabwe CVD, DM, RD Depression SES
FoC
Carpenter, 2022 NR NR South Africa CVD, DM, RD General MH Stigma
FoC
Chang, 2019 40+ Female (1619) South Africa CVD, DM Depression Stigma
FoC
LoR
Gooden, 2023 20+ Male (14) and Female (22) Tanzania CVD, DM General MH SES
Stigma
FoC
LoR
Jere, 2023 37-66 Male (25) Malawi CVD, DM Depression LoR
FoC
Magafu, 2013 18+ Male (112) Tanzania CVD, DM, RD, Cancer General MH FoC
Mendenhall, 2015 35-65 Male (50) Kenya CVD, DM Depression LoR
FoC
Mendenhall, 2019 NR Male (30) and Female (50) South Africa CVD, DM, Cancer Depression SES
FoC
Mutagonda, 2022 18+ Male (402) Tanzania CVD, DM, Cancer Depression FoC
LoR
Qubekile, 2022 18+ Male (37) and Female (63) South Africa DM Depression FoC
SES
Smit, 2018 19+ Male and Female Zimbabwe CVD, DM, RD, Cancer Depression FoC
LoR
Tomita, 2021 40+ Male and Tomita Tanzania CVD, DM Depression FoC
SES

Studies are listed in alphabetical order by authors last name; -: No data available; SES; Socioeconomic Status; LoR: Lack of Resources; FoC: Fragmentation of Care; CVD: Cardiovascular Disease; DM: Diabetes Mellitus; MH: Mental Health; RD, Respiratory disease; NR; Not Reported; General MH: No classification of MH.

Fig 3. Heat map displaying the distribution of studies across eight countries, highlighting the relative number of studies in each region.

Fig 3

South Africa has the highest concentration with 5 studies, followed by Tanzania with 4 studies, and Zimbabwe with 2 studies. Kenya, Uganda, Rwanda, Malawi, Cameroon, and Ghana are each represented by 1 study. The color gradient on the map visually reflects the number of studies, with darker shades indicating higher concentrations and lighter shades indicating lower concentrations in each country. Created in BioRender. Karbasi, A. (2025) https://BioRender.com/p7tc1x2.

3.3 Syndemic interplay of HIV, NCDs, and MH

Publications on the prevalence of complex multi-morbidities among PLWH has predominantly been conducted in East African countries of Zimbabwe and Tanzania (n = 9, 53%) followed by Southern Africa (Fig 3). This geographical focus underscores a significant gap in the broader understanding of these interrelated conditions across other regions of Africa (e.g., West and Northern Africa. Overall, several studies (n = 6, 35%) found that participants often had uncontrolled diseases, and nearly all individuals diagnosed with MH disorders were previously undiagnosed [50,51]. Researchers used existing datasets to develop a model forecasting NCD patterns among PLWH in Zimbabwe [50]. A significant number of PLWH currently experience NCDs including hypertension, with either chronic kidney disease (CKD) (34%), depression (20%), diabetes (10%), cancer (9%), asthma (8%), and stroke (3%) (Fig 4A). Although the epidemiological shift towards NCDs in Africa trends to be similar among PLWH and HIV-negative persons, notable differences by HIV status indicate that the major contributing multi-morbidity profiles amongst HIV-negative individuals have two NCDs, while a large proportion of PLWH have three NCDs [50]. These estimates, however, may be inaccurate due to limited comprehensive data.

Fig 4. (A) Prevalence of multi-morbidities across different sex-age groups.

Fig 4

The sample sizes for females and males are as follows: 40-49 years (n= 1084), 50-59 years (n = 607), 60-69 years (n = 369), and 70 + years (n = 190). The graph highlights the distribution of multi-morbidity rates by age and sex, providing insights into the variation across different demographic groups. (B) Depiction of the prevalence of PLWH with two or more NCDs in 2015 (n = 100) and projected for 2035 (n = 100). CKD: Chronic Kidney Disease; NCD: Non-communicable disease.

A separate study in Tanzania explored multi-morbidity and its association with hospitalizations in aging populations, identified a rapidly growing burden of multi-morbidity, significantly being influenced by factors such as urbanization, food insecurity, and socioeconomic variables [51]. In a sample of 2,299 adults (age 40 yrs and older), 17.1% had two health conditions, 6.2% had three, and 2% had more than four [52]. The study also revealed that approximately 40% of PLWH also had NCDs and depression, underscoring the frequent co-occurrence of these conditions [52]. In South Africa, participants had an average of 2.3 comorbidities, with 73% of PLWH diagnosed with two or more conditions [53]. Hypertension was the most common comorbidity, among PLWH. While few participants were formally diagnosed with anxiety or depression, all reported high depressive symptoms based on the Center for Epidemiologic Studies Depression Scale (CES-D) suggesting poor diagnosis rates for MH conditions among PLWH [53].

In Tanzania, a study of 1,318 PLWH found that 14.3% reported common NCDs such as hypertension, diabetes, and cancer, with prevalence ranging from 15% to 58% depending on the setting, likely due to self-reported diagnoses and limited NCD screening [51]. Depression was strongly associated with NCDs, particularly among those with cancer, who were four times more likely to experience depression [51]. Similarly, PLWH diagnosed with an NCD were 3.4 times more likely to score below the MH mean comparison to the general population [54].

A study in Zimbabwe with 6,598 participants found that among individuals over 50, 39% exhibited multi-morbidity, with 7% experiencing complex multi-morbidity involving conditions, such as hypertension, HIV/AIDS, diabetes, and MH disorders [55]. Across these five reports, researchers noted that the type of NCD, rather than the number of comorbidities, significantly influenced how PLWH prioritized health conditions. [5052,54,55]. Patients often prioritized familiar or distressing conditions over those emphasized by clinicians, highlighting the need to improve health literacy among PLWH to better align patient priorities with evidence-based care [53]. These findings highlight the inadequate integration of MH screening into routine clinical care for PLWH, suggesting that the burden of MH challenges is significantly underestimated in the literature. The results also indicate that MH challenges may play a more substantial role in health outcomes than previously anticipated.

3.4 Gender differences and age-related trends in multi-morbidity among PLWH

Two publications conducted in Zimbabwe and Tanzania demonstrated that women are disproportionately affected by multi-morbidity, including hypertension, diabetes mellitus, cervical cancer as well as other significant NCDs [50,52]. One study revealed notable gender disparities in the prevalence of complex multi-morbidities, highlighting that woman aged 60–69 and 70 + experience significantly higher mortality rates compared to men [50] (Fig 4B). Additionally, another study examining the prevalence and predictors of common NCDs among PLWH found that women over 45 years old and weighing more than 75 kg had higher odds of having an NCD, with depression prevalence of 11.8% in this group [51]. Several studies also indicate a higher proportion of women in HIV/AIDS studies, reflecting the greater prevalence of HIV/AIDS among women (6.3% vs. 3.9%) [51]. These observed disparities may be influenced by a combination of methodological and contextual factors, including variations in sampling strategies, differences in research design, and broader societal trends in female participation in research, which may affect both the likelihood of women being included in studies and their willingness or ability to participate.

In South Africa, a study investigating the comorbidity of HIV/AIDS and diabetes mellitus found no significant association with moderate to severe depressive symptoms and clinical variables such as type and complications of diabetes. Gender and educational level were significantly associated with depressive symptoms [56]. These findings are consistent with boarder research showing that women are 1.75 times more likely to experience lifetime depression than men [51,56].

Other reports have underscored the significance of age and HIV/AIDS status in the development of complex multi-morbidities [5052]. For example, one study revealed that PLWH were more likely to be diagnosed with single or multiple comorbidities compared to HIV-negative individuals. Approximately 33% of PLWH were diagnosed with at least one NCD, compared to 14% of HIV-negative persons [50]. Even without additional NCD risk from HIV or ART, 26% of PLWH would still develop one or more NCDs due to their older average age. This difference in the prevalence of multi-morbidities by HIV status is expected to increase, with projections indicating that the proportion of PLWH diagnosed with at least one NCD will rise from 33% in 2015 to 59% in 2035, and those with two or more NCDs will increase from 5% to 16% over the same period [50].

In two additional publications, the majority of NCDs were either undiagnosed or inadequately controlled, and multi-morbidity was more prevalent among older PLWH [55,57]. Finally, one study exploring the prevalence of diabetes, HIV/AIDS, and MH found that 15% of women and 13% of men, experienced multi-morbidity, with prevalence rates increasing with age [55]. Among individuals aged 50 and older, 39% had multi-morbidity, and 7% had three or more chronic conditions [55]. These findings underscore the growing burden of multi-morbidity among PLWH, particularly among women and older adults, highlighting the urgent need for gender-sensitive and age-appropriate interventions. Addressing these disparities requires targeted screening, early diagnosis, and comprehensive management of NCDs alongside HIV/AIDS care. Additionally, strengthening health systems to improve access to integrated services and addressing the social determinants of health will be essential in mitigating the impact of multi-morbidities on vulnerable populations.

3.5 Contextual factors for strengthening holistic care

Several studies emphasized the urgent need to develop and strengthen health systems to improve screening and diagnostics, thereby preventing the progression of these diseases [5066]. A recurring theme across all reports was the impact of (i) addressing fragmented care via integration, (ii) resource limitations, (iii) socioeconomic determents and (iv), HIV-related stigma on health outcomes for PLWH [5066] (Fig 5). Large-scale success of implementation and scale-up of a’treat-all’ model requires understanding the known barriers to achieving optimal HIV care within a healthcare setting. MH disorders are common among PLWH, yet they often remain undiagnosed and undertreated in low-resource settings, complicating efforts to develop tailored interventions for syndemic conditions. Organizations in these regions are actively working to address these gaps through policy advocacy, education, and integrating mental health care into existing healthcare systems. In Ghana, ABANTU for development is working to overcome socioeconomic barriers limiting access to NCD treatment for PLWH, despite the availability of free antiretroviral therapy. Through advocacy and educational programs, the organization strives to improve access to comprehensive care [67]. Similarly, in Uganda, StrongMinds is partnering with HIV-focused groups to integrate MH support into HIV/AIDS and NCD care models. Despite facing challenges like limited infrastructure and stigma, their collaboration emphasizes the need for greater investment in a holistic, patient-centered care model [68]. These efforts reinforce the urgency of developing comprehensive training programs that integrate HIV/AIDS, NCD, and MH care to ensure individuals receive the care they need and deserve.

Fig 5. The interplay between HIV/AIDS, NCDs, and MH syndemics, illustrating how stigma, socioeconomic status, fragmented healthcare systems, and resource scarcity collectively impact health outcomes.

Fig 5

Findings from our scoping review suggest that these interconnected factors, as reported in the literature, significantly influence the co-occurrence of NCDs and MH disorders among PLWH in Africa, exacerbating health inequities and posing substantial challenges to integrated care delivery.

3.5.1 Integrated care for complex health needs: Addressing the syndemic of HIV, NCDs, and MH in Africa.

Of the several contextual factors identified in the scoping review that influenced the HIV-syndemic, the most notable challenges included fragmented care for individuals with complex multi-morbidities. Fragmented care not only introduces inefficiencies into the healthcare system but is exacerbated as social determinants including poverty, stigma, and inadequate infrastructure, which further complicate these conditions. Studies have found significant associations between fragmented care and negative patient outcomes (e.g., un-necessary testing, increased hospitalization rates and medical costs) [59]. By integrating care and enhancing communication among healthcare providers, systems can address not only individual diseases but also the underlying factors contributing to poor health outcomes [50,51,57,60].

In Uganda, a pilot program integrating HIV, diabetes, and hypertension care demonstrated the benefits of leveraging existing healthcare infrastructure to provide more coordinated care [61]. Integration was also seen as an opportunity to reduce the stigma associated with seeking treatment at HIV clinics, as patients felt that it concealed their HIV status and minimized HIV-related stigma. Participants in the study reiterated that integrating NCDs into HIV care could alleviate stigma while addressing the other barriers that hindered healthcare seeking behavior for comorbid conditions [61]. In South Africa, a country-level analysis further highlighted the growing burden of disabilities; with the combination of chronic HIV/AIDS, rising NCD prevalence, and an aging population necessitates enhanced screening and treatment services. However, these services have not yet been fully implemented [62]. The publication highlighted interventions aimed at improving identification, linking patients to care, and providing wellness programs could significantly improve public health. Additionally, it stressed the need for integrate MH services into chronic disease management, noting that evidence-based MH interventions are often neglected despite their importance in managing comorbidities [62].

The growing complexity of health needs in South Africa highlights the importance of person-centered, integrated care [53]. While implementing such models in resource-constrained settings is challenging, leveraging local institutional strengths to provide more integrated care is essential for improving patient outcomes [53].

Numerous reports called for enhanced screening and treatment for NCDs and MH disorders within HIV/AIDS care, alongside intensified prevention efforts [50,51,56,57,63]. One study found that care integration could reduce medical costs and improve quality, highlighting one of the major benefits of integrated services [23]. A study in Malawi highlighted that successful integration of care for individuals with complex multi-morbidities depended on strengthening health systems through training and capacity building resulting in improved care quality and better patient outcomes [63]. Additionally, other research emphasized the need for integration via coordinated, patient-centered medical visits, which include comprehensive testing and treatment, as part of a holistic approach to care [64]. Finally, several studies also noted that integration could significantly reduce barriers to access for PLWH, such as discontinuity in care, limited access to healthcare, and the need for greater education on managing these health conditions [51,57,58]. Together, these findings underscore the critical need for integrated, patient-centered care models that address the complex health needs of PLWH, while simultaneously strengthening health systems to improve access, quality, and long-term health outcomes.

3.5.2 Addressing resources limitations.

Resource constraints can severely hinder the delivery of quality care. The increasing burden of NCDs further strains already fragile healthcare systems, underscoring the need for cost-effective models to manage both HIV and NCDs [50]. Across Africa, research has highlighted the inadequacy of infrastructure for recording and monitoring NCDs and related risk factors, leading to missed opportunities to prevent complex multi-morbidities through essential screening and prevention services [46,51,57,65]. As critical data is not captured and individuals remain unaware of their conditions, there remains a lack of comprehensive understanding and treatment of MH issues and NCDs [50,51,55,57]. Efforts to improve real-time data capture and implement integrated care models have faced significant barriers. For instance, in South Africa examining the implementation of an Integrated Chronic Disease Management model identified staff shortages and drug stock-outs as significant obstacles, leading to fewer patient visits and shorter consultation times with providers [66]. Although some settings have partially integrated care for NCDs, HIV, and MH, full integration remains limited due to ongoing resource constraints at the clinic level [66]. Addressing these challenges requires sustained investment in healthcare infrastructure, workforce capacity, and innovative data management systems to enhance service delivery. Strengthening integrated care models will be essential to effectively manage the dual burden of HIV and NCDs, ensuring that healthcare systems can provide comprehensive, patient-centered care despite resource limitations.

3.5.3 Socioeconomic determinants of health: The impact of poverty, education, and food insecurity on multi-morbidities in HIV, NCDs, and MH.

A recurring contextual factor is the challenging socioeconomic status of individuals. A study in South Africa found that low educational levels were strongly associated with depression, while higher education had a protective effect that accumulated over the lifetime [50]. Other studies with patients experiencing complex multi-morbidities revealed that many struggled with poverty, often citing difficulties in affording transportation to clinics, medications, and food [11,57,69]. In Ghana, although antiretroviral treatment is provided for free, patients reported challenges in affording medications for hypertension and diabetes, often relying on financial assistance from others [69]. Food insecurity, linked to poor socioeconomic conditions, is also associated with higher rates of multi-morbidities, underscoring the connection between socioeconomic status and health outcomes in individuals living with HIV, NCDs, and MH conditions [69]. These findings underscore the profound influence of socioeconomic factors on health outcomes, particularly for individuals managing HIV, NCDs, and MH conditions. Policies that enhance financial support, expand access to affordable medications (e.g., hypertension and diabetes management) and improve food security can play a crucial role in mitigating the impact of poverty on health. Furthermore, integrating social and economic interventions into healthcare models may provide a more sustainable approach to managing multi-morbidities in resource-limited settings.

3.5.4 The role of HIV-related stigma as barriers to care and treatment adherence.

Stigma related to HIV/AIDS, MH, and NCDs emerged as a prominent factor worsening the relationship between these conditions [61,69]. One study found that HIV/AIDS patients with comorbid conditions frequently experienced feelings of depression, loneliness, and hopelessness [69]. HIV-related stigma, coupled with a lack of support, led to worsened emotions – discouraging patients from seeking care or adhering to their treatment for other conditions. Stigma and lack of support were highlighted as significant barriers to treatment adherence and care-seeking behaviors of PLWH [69]. In Uganda, another study observed that the healthcare system was heavily impacted by HIV-related stigma. Participants reported experiencing stigma in various social settings, particularly related to the intersection of HIV and NCDs [61]. Efforts to reduce stigma and promote supportive environments are critical for improving health outcomes among PLWH with comorbid conditions. Implementing community-based interventions, providing mental health support, and fostering patient-provider trust can help mitigate stigma-related barriers. Additionally, integrating stigma reduction strategies into healthcare services may enhance treatment adherence and encourage care-seeking behaviors, ultimately improving overall well-being.

3.6 Quality assessment

Quality assessment of qualitative studies (n = 5) indicated that at least 80% of all qualitative research studies had a low risk of bias (RoB) across all indicators for the quality of evidence gathered in the studies. RoB assessment of cross-sectional studies (n = 7) indicated a high risk of bias amongst measurements of exposures and stated conditions within half of the specific studies. RoB assessment of a singular mixed methods study (n = 1) had a low RoB across all indicators for assessing the quality of evidence for this type of study design except for failing to sufficiently address inconsistences between qualitative and quantitative results.

Given the heterogeneity in study designs, a formal risk of bias assessment was conducted only for the qualitative, mixed methods, and cross-sectional studies, as these were the most methodologically appropriate for the appraisal tool utilized and most relevant to the review objectives. Other study types, such as simulation models or secondary analysis, were reviewed for relevance and basic methodological rigor but were not included in the formal RoB scoring (Fig 6).

Fig 6. (A) Quality assessment of qualitative studies (n = 5).

Fig 6

Two qualitative studies were found to have an overall low risk, with two have some concerns, and one having high risk. (B) Quality assessment of cross-sectional studies (n = 7). One of the cross-sectional studies had low risk, one was found to have some concerns, and five were found to have high risk. (C) Quality assessment of mixed-methods studies (n = 1). The lone study included in this paper was found to have high risk.

Final assessment of the included research demonstrated that 29.41% (n = 5) received an overall assessment of 5; 41.18% (n = 7) received an overall assessment of 4; 29.41% (n = 5) received an overall assessment of 3 and none received an overall assessment of 2 or 1. The average assessment was 3.4, indicating that there is a slight risk within the results. One major source of bias that may have affected outcome reporting is that within the cross-sectional designs, self-reporting was utilized. The utilization of self-reporting may have affected the validity of the outcomes by under-reporting or over-reporting the factors discussed at length. Nonetheless, the use of effect measures may have been impossible given the scope of the research question and the nature of the studies themselves. The quality assessment is characterized below (Fig 6).

4. Discussion

This scoping review is the first to synthesize current evidence on relationship between HIV/AIDS, MH disorders, and NCDs in the African region. Our review of 17 articles identified several multi-level factors contributing to the co-occurrence of these synergistic epidemics. We found that most of the research were conducted in East and Southern Africa (i.e., Tanzania and South Africa), with a smaller number of reports from other countries within West and Central Africa and no studies in the North African region. Additionally, in one study a correlational matrix was used to discern a relationship between HIV/NCD/MH revealing a particularly strong relationship between HIV and stroke, as well as a notable correlation between stroke and depression, demonstrating that each condition can independently influence the other [52]. This data is consistent with previous publications included in this review understanding complex multi-morbidities within isolated regions in Africa [5055].

Contextual factors such as fragmented care, resource scarcity within healthcare systems, stigma, discrimination, and socioeconomic determinants were identified as significant contributors to the exacerbation of these conditions. Disruptions in care, which are often amplified by the co-management of multiple health conditions, can severely impact the HIV/AIDS and NCD care cascade, resulting in reduced care-seeking behaviors and worsened health outcomes for individuals with complex multi-morbidities. Future research should consider collecting data on contextual factors (e.g., care integration, resource limitations, socioeconomic determents, HIV-related stigma) that underpin syndemics occurring to better elucidate these relationships to disease outcomes among PLWH.

The syndemic framework provides valuable insight into the dual burden of MH disorders and NCDs among PLWH. The lack of robust healthcare infrastructure, which fails to accurately capture data from the population, adds to the challenges faced by communities already dealing with longstanding inequities. For instance, a recent study highlighted the lack of data on NCDs and risk factors in the clinical care of adolescents with HIV, underscoring missed opportunities for detecting and addressing comorbidities [70]. Managing the triple burden of HIV/AIDS, MH disorders, and NCDs introduces a new level of complexity and stress for PLWH. Moreover, the difference in the prevalence of multi-morbidities by HIV/AIDS status is expected to increase, with projections indicating that the proportion of PLWH diagnosed with at least one NCD will rise from 33% in 2015 to 59% in 2035, and those with two or more NCDs will increase from 5% to 16% over the same period [50]. While ART has greatly improved life expectancy, with many living into their 60s and beyond, this demographic shift has also increased the prevalence of comorbid conditions, including both physical and MH challenges. Our analysis of various reports support this finding by demonstrating that HIV-associated non-AIDS conditions—such as CVD, diabetes, renal disease, and cancer—are more common in older PLWH [71].

Gender disparities multi-morbidities were also evident, with women living with HIV/AIDS disproportionately affected compared to men. This disparity is shaped by both biological and socio-cultural factors. Women with HIV/AIDS often face unique socioeconomic determinants, such as gender-based violence, caregiving responsibilities, and economic inequality, all of which increase their vulnerability to both physical and MH issues. Women were more likely to report symptoms of depression and anxiety, which, when compounded by HIV-related stressors and multi-morbidities, can negatively affect treatment adherence and overall health outcomes [50,51,56]. Addressing the intersection of gender, HIV/AIDS, and multi-morbidities requires a tailored approach that considers the specific needs of women in HIV/AIDS care models and recognizes both gender and health disparities.

A key finding across literature is the need for improved integration of MH and NCDs screening and services within existing HIV/AIDS care frameworks. Many PLWH also face MH challenges, which exacerbate their overall health outcomes. These intertwined challenges are further complicated by social determinants such as socioeconomic status, HIV-related stigma, and inadequate healthcare resources, all of which hinder access to necessary care. To address these multifaceted issues, a comprehensive and adaptable approach is needed, one that prioritizes integrated service delivery to ensure individuals receive care that addresses their physical, mental, and social well-being. Organizations are addressing gaps in care through community-based interventions, peer counseling, and integrated care models that enhance treatment adherence and access to holistic healthcare. Specifically, in Malawi, resource constraints and fragmented care delay NCD diagnosis and management for PLWH. Partners in Health Malawi strengthens the health system by integrating mental health support into HIV and NCD treatment [72]. In Tanzania, the growing burden of multimorbidity, worsened by food insecurity and economic instability, highlights the need for expanded integrated care. TNW+ provides peer counseling and advocacy for women living with HIV, addressing the intersection of these conditions [73]. In Zimbabwe, Zvandiri’s peer-led model helps older PLWH manage depression and cardiovascular diseases, improving adherence and bridging gaps in service integration [74]. These examples highlight the pressing need for scalable, patient-centered solutions that integrate HIV, NCD, and mental health services within existing healthcare frameworks.

Reducing HIV-related stigma and integrating MH is also crucial, as stigma often discourages individuals from seeking care or adhering to treatment. Integrated care models that create supportive, non-judgmental environments can reduce stigma and improve health outcomes by encouraging patients to disclose their health challenges.

Socioeconomic factors and resource limitations play a significant role in amplifying the syndemic between HIV/AIDS, NCDs, and MH. Individuals from lower socioeconomic backgrounds face additional barriers to healthcare access, such as food insecurity, unemployment, and limited education, which hinder effective health management. The reviewed reports highlight how these factors contribute to poor health cycles and mental distress, further reinforcing the syndemic relationship. As the population ages and the prevalence of NCDs rises, there is an increasing need for targeted evidence-based interventions that address the unique challenges posed by resource constraints and socioeconomic disparities [7074].

4.1 Lack of syndemic literature in PLWH in Africa

Our scoping review has some limitations. One of the primary challenges is the limited literature on syndemic interactions among African populations. While syndemics have been thorough examined in high-income countries, there is a dearth of research specifically focused on the unique contextual factors and experiences of PLWH in Africa. The growing burden NCDs among PLWH in the African context highlights the urgent need for more research that takes a syndemics approach. Such research would help identify the distinct socio-economic, cultural, and healthcare system factors that influence the co-occurrence of HIV/AIDS, NCDs, and MH disorders, ultimately improving health outcomes for PLWH in Africa.

Notably, our review also revealed an absence of studies focused on children and adolescents living with HIV. All included studies enrolled adults aged 18 years or older, with many skewed toward older populations. This is an important gap, as children and young PLWH, particularly in relation to mental health and syndemic risk, remain significantly underrepresented in the literature. As noted in other studies of HIV-associated MH, youth are often neglected in research on depression and HIV, a pattern seen here [75]. While some NCDs may be more common in older adults, others such as CVD and RD, can have major impacts in younger populations, reinforcing the need to include them in syndemics research [76].

Furthermore, in our scoping review, while we identified common themes across studies, we were unable to assess the methodological rigor of the publications. This lack of detailed assessment limits the ability to determine the quality and reliability of the evidence. The review only included published articles between 2000 and 2023, making it likely to potentially underestimate the burden of the syndemic within the region. Moreover, due to the heterogeneity of the various publications, we were unable to conduct a meta-analysis or aggregate statistical analysis to quantify the prevalence of NCDs and HIV/AIDS comorbidities among PLWH within our scoping review. Therefore, future studies should prioritize inclusion of younger populations, adopt robust and consistent methodologies, and collect comparable data across larger samples to enable more definitive conclusions and inform effective interventions.

5. Conclusion

This scoping review summarizes the current evidence on NCDs and MH among PLWH, highlighting the growing prominence of complex multi-morbidities over time. While the publications primarily focused on understanding the relationships between co-morbid conditions and the experiences of individuals living with these conditions, they also revealed significant challenges, including fragmented healthcare systems and a lack of MH literacy among healthcare providers. Furthermore, broader socio-economic factors, such as poverty and stigma, continue to hinder access to quality care. The findings emphasize the urgent need for health system reforms to address these systemic barriers, including improved clinic organization, stronger healthcare infrastructure, and policies that support holistic care for patients with NCDs and MH disorders.

Addressing the HIV/AIDS syndemic of MH, and NCDs requires a comprehensive, integrated approach that not only treats individual conditions but also addresses the underlying social and economic determinants driving these health challenges. Advancing integrated care models, alongside necessary health system reforms and contextually relevant interventions, holds significant potential to improve health outcomes and enhance the overall quality of life for individuals facing the dual burden of MH and NCDs.

Supporting information

S1 Appendix. Search strategy.

For our search strategy, the search items included: Non-communicable Diseases (i.e., Cardiovascular Disease, Cancer, Kidney Disease, Respiratory Diseases, and Diabetes), Mental Health (i.e., Mood disorders, substance-use disorders, anxiety disorders, Stigma), and People living with HIV. The search limits included the following: publication year of 2000–2024, no language restrictions, geography of Sub-saharan Africa, and studies focusing specifically on examining the impact of HIV and mental health on the prevalence and management of Non-communicable Diseases.

(DOCX)

pone.0328515.s001.docx (36.8KB, docx)
S2 Appendix. PRISMA-ScR-Checklist.

Illustrates the selection procedure for studies including in this scoping review. Additionally, it follows the PRISMA Scoping Review guidelines.

(PDF)

pone.0328515.s002.pdf (644.7KB, pdf)
S3 Appendix. Multi-morbidity trends among people living with HIV.

Demonstrates the prevalence of multi-morbidities across sex and age groups among PLWH (Panel A), and the proportion of individuals with two or more NCDs in 2015 and projected for 2035 (Panel B). Provides a demographic insight into the changing burden of NCDs over time.

(XLSX)

pone.0328515.s003.xlsx (9.7KB, xlsx)

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Rudd KE, Mair CF, Angus DC. Applying syndemic theory to acute illness. JAMA. 2022;327(1):33–4. doi: 10.1001/jama.2021.22583 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Dixon J, Mendenhall E. Syndemic thinking to address multimorbidity and its structural determinants. Nat Rev Dis Primers. 2023;9(1):23. doi: 10.1038/s41572-023-00437-2 [DOI] [PubMed] [Google Scholar]
  • 3.Mendenhall E, Kohrt BA, Logie CH, Tsai AC. Syndemics and clinical science. Nat Med. 2022;28(7):1359–62. doi: 10.1038/s41591-022-01888-y [DOI] [PubMed] [Google Scholar]
  • 4.The Lancet. Syndemics: health in context. Lancet. 2017;389(10072):881. doi: 10.1016/S0140-6736(17)30640-2 [DOI] [PubMed] [Google Scholar]
  • 5.Tsai AC, Venkataramani AS. Syndemics and health disparities: a methodological note. AIDS Behav. 2016;20(2):423–30. doi: 10.1007/s10461-015-1260-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Ojo T, Ruan C, Hameed T, Malburg C, Thunga S, Smith J. HIV, tuberculosis, and food insecurity in Africa-a syndemics-based scoping review. Int J Environ Res Public Health. 2022;19(3). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wong EB, Olivier S, Gunda R, Koole O, Surujdeen A, Gareta D, et al. Convergence of infectious and non-communicable disease epidemics in rural South Africa: a cross-sectional, population-based multimorbidity study. Lancet Glob Health. 2021;9(7):e967–76. doi: 10.1016/S2214-109X(21)00176-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Cuadros DF, Devi C, Singh U, Olivier S, Castle A, Moosa Y, et al. Convergence of HIV and non-communicable disease epidemics: geospatial mapping of the unmet health needs in a HIV Hyperendemic South African community. medRxiv. 2023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Marmot M, Friel S, Bell R, Houweling TAJ, Taylor S, Commission on Social Determinants of Health. Closing the gap in a generation: health equity through action on the social determinants of health. Lancet. 2008;372(9650):1661–9. doi: 10.1016/S0140-6736(08)61690-6 [DOI] [PubMed] [Google Scholar]
  • 10.Yadav UN, Rayamajhee B, Mistry SK, Parsekar SS, Mishra SK. A syndemic perspective on the management of non-communicable diseases amid the COVID-19 pandemic in low- and middle-income countries. Front Public Health. 2020;8:508. doi: 10.3389/fpubh.2020.00508 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Mendenhall E, Kohrt BA, Norris SA, Ndetei D, Prabhakaran D. Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations. Lancet. 2017;389(10072):951–63. doi: 10.1016/S0140-6736(17)30402-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.HIV/AIDS. World Health Organization; n.d. [cited 2024 Nov 22]. Available from: https://www.afro.who.int/health-topics/hivaids [Google Scholar]
  • 13.Peprah E, Armstrong-Hough M, Cook SH, Mukasa B, Taylor JY, Xu H, et al. An emerging syndemic of smoking and cardiopulmonary diseases in people living with HIV in Africa. Int J Environ Res Public Health. 2021;18(6):3111. doi: 10.3390/ijerph18063111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Omosigho PO, John OO, Musa MB, Aboelhassan YMEI, Olabode ON, Bouaddi O, et al. Stigma and infectious diseases in Africa: examining impact and strategies for reduction. Ann Med Surg (Lond). 2023;85(12):6078–82. doi: 10.1097/MS9.0000000000001470 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Pence BW, O’Donnell JK, Gaynes BN. Falling through the cracks: the gaps between depression prevalence, diagnosis, treatment, and response in HIV care. AIDS. 2012;26(5):656–8. doi: 10.1097/QAD.0b013e3283519aae [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ji J, Zhang Y, Ma Y, Jia L, Cai M, Li Z, et al. People who living with HIV/AIDS also have a high prevalence of anxiety disorders: a systematic review and meta-analysis. Front Psychiatry. 2024;15:1259290. doi: 10.3389/fpsyt.2024.1259290 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Remien RH, Stirratt MJ, Nguyen N, Robbins RN, Pala AN, Mellins CA. Mental health and HIV/AIDS: the need for an integrated response. AIDS. 2019;33(9):1411–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Wondimagegn D, Pain C, Seifu N, Cartmill C, Alemu AA, Whitehead CR. Reimagining global mental health in Africa. BMJ Glob Health. 2023;8(9):e013232. doi: 10.1136/bmjgh-2023-013232 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Wada YH, Rajwani L, Anyam E, Karikari E, Njikizana M, Srour L, et al. Mental health in Nigeria: a neglected issue in public health. Public Health Pract (Oxf). 2021;2:100166. doi: 10.1016/j.puhip.2021.100166 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Jaeschke K, Hanna F, Ali S, Chowdhary N, Dua T, Charlson F. Global estimates of service coverage for severe mental disorders: findings from the WHO Mental Health Atlas 2017 - Addendum. Glob Ment Health (Camb). 2021;8:e28. doi: 10.1017/gmh.2021.30 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Sankoh O, Sevalie S, Weston M. Mental health in Africa. Lancet Glob Health. 2018;6:e954-5. [DOI] [PubMed] [Google Scholar]
  • 22.World health Atlas 202. Geneva: World Health Organization; 2021. [cited 2025 Jan 11]. Available from: https://www.who.int/publications/i/item/9789240036703 [Google Scholar]
  • 23.Non communicable diseases. World Health Organization. [cited 2024 Nov 22]. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases [Google Scholar]
  • 24.Bigna JJ, Noubiap JJ. The rising burden of non-communicable diseases in sub-Saharan Africa. Lancet Glob Health. 2019;7(10):e1295–6. doi: 10.1016/S2214-109X(19)30370-5 [DOI] [PubMed] [Google Scholar]
  • 25.Peer N. The converging burdens of infectious and non-communicable diseases in rural-to-urban migrant Sub-Saharan African populations: a focus on HIV/AIDS, tuberculosis and cardio-metabolic diseases. Trop Dis Travel Med Vaccines. 2015;1:6. doi: 10.1186/s40794-015-0007-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Moyo-Chilufya M, Maluleke K, Kgarosi K, Muyoyeta M, Hongoro C, Musekiwa A. The burden of non-communicable diseases among people living with HIV in Sub-Saharan Africa: a systematic review and meta-analysis. EClinicalMedicine. 2023;65:102255. doi: 10.1016/j.eclinm.2023.102255 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Bhuiyan MA, Galdes N, Cuschieri S, Hu P. A comparative systematic review of risk factors, prevalence, and challenges contributing to non-communicable diseases in South Asia, Africa, and Caribbeans. J Health Popul Nutr. 2024;43(1):140. doi: 10.1186/s41043-024-00607-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Owolade A, Mashavakure H, Babatunde AO, Aborode AT. Time to relook into non-communicable diseases (NCDs) in Africa: a silent threat overwhelming global health in Africa. Ann Med Surg (Lond). 2022;82:104522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Bickler SW, Wang A, Amin S, Halbach J, Lizardo R, Cauvi DM, et al. Urbanization in sub-Saharan Africa: declining rates of chronic and recurrent infection and their possible role in the origins of non-communicable diseases. World J Surg. 2018;42(6):1617–28. doi: 10.1007/s00268-017-4389-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Azevedo MJ. Historical perspectives on the state of health and health systems in Africa, volume I: the pre-colonial and colonial eras. 1st ed. Cham: Springer International Publishing: Imprint: Palgrave Macmillan; 2017. [Google Scholar]
  • 31.Stein DJ, Benjet C, Gureje O, Lund C, Scott KM, Poznyak V, et al. Integrating mental health with other non-communicable diseases. BMJ. 2019;364:l295. doi: 10.1136/bmj.l295 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Gyawali B, Harasym MC, Hassan S, Cooper K, Boschma A, Bird M, et al. Not an “either/or”: Integrating mental health and psychosocial support within non-communicable disease prevention and care in humanitarian response. J Glob Health. 2021;11:03119. doi: 10.7189/jogh.11.03119 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Mental health. CMHA Ontario; n.d. [cited 2024 Nov 22]. Available from: https://ontario.cmha.ca/documents/the-relationship-between-mental-health-mental-illness-and-chronic-physical-conditions/ [Google Scholar]
  • 34.Mezzina R, Gopikumar V, Jenkins J, Saraceno B, Sashidharan SP. Social vulnerability and mental health inequalities in the “syndemic”: call for action. Front Psychiatry. 2022;13:894370. doi: 10.3389/fpsyt.2022.894370 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Andrulis DP, Brach C. Integrating literacy, culture, and language to improve health care quality for diverse populations. Am J Health Behav. 2007;31 Suppl 1(Suppl 1):S122-33. doi: 10.5555/ajhb.2007.31.supp.S122 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Henderson C, Evans-Lacko S, Thornicroft G. Mental illness stigma, help seeking, and public health programs. Am J Public Health. 2013;103(5):777–80. doi: 10.2105/AJPH.2012.301056 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Nyblade L, Stockton MA, Giger K, Bond V, Ekstrand ML, Lean RM, et al. Stigma in health facilities: why it matters and how we can change it. BMC Med. 2019;17(1):25. doi: 10.1186/s12916-019-1256-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Ramos NNV, Fronteira I, Martins M do RO. Comprehensive knowledge of HIV and AIDS and related factors in Angolans aged between 15 and 49 years. Int J Environ Res Public Health. 2023;20(19):6816. doi: 10.3390/ijerph20196816 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Health - United Nations Sustainable Development. United Nations; n.d. [cited 2024 Nov 22]. Available from: https://www.un.org/sustainabledevelopment/health/ [Google Scholar]
  • 40.Adeyemi O, Lyons M, Njim T, Okebe J, Birungi J, Nana K, et al. Integration of non-communicable disease and HIV/AIDS management: a review of healthcare policies and plans in East Africa. BMJ Glob Health. 2021;6(5):e004669. doi: 10.1136/bmjgh-2020-004669 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Godfrey C, Nkengasong J. Prioritizing mental health in the HIV/AIDS response in Africa. N Engl J Med. 2023;389(7):581–3. doi: 10.1056/NEJMp2305399 [DOI] [PubMed] [Google Scholar]
  • 42.Patel P, Rose CE, Collins PY, Nuche-Berenguer B, Sahasrabuddhe VV, Peprah E, et al. Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis. AIDS. 2018;32 Suppl 1(Suppl 1):S5–20. doi: 10.1097/QAD.0000000000001888 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Uthman OA, Magidson JF, Safren SA, Nachega JB. Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis. Curr HIV/AIDS Rep. 2014;11(3):291–307. doi: 10.1007/s11904-014-0220-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Lampe FC. Increased risk of mental illness in people with HIV. Lancet HIV. 2022;9(3):e142–4. doi: 10.1016/S2352-3018(22)00034-0 [DOI] [PubMed] [Google Scholar]
  • 45.Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8:19–32. [Google Scholar]
  • 46.Critical-appraisal-tools—Critical appraisal tools. Adelaide, Australia: Joanna Briggs Institute. [cited 2021 Dec 9]. Available from: https://jbi.global/critical-appraisal-tools [Google Scholar]
  • 47.Brice R. Casp checklists. CASP—Critical Appraisal Skills Programme Web Site. [cited 2021 Dec 9]. Available from: https://casp-uk.b-cdn.net/wp-content/uploads/2018/03/CASP-Qualitative-Checklist-2018_fillable_form.pdf [Google Scholar]
  • 48.Hong QN, Fàbregues S, Bartlett G, Boardman F, Cargo M, Dagenais P, et al. The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers. EFI. 2018;34(4):285–91. doi: 10.3233/efi-180221 [DOI] [Google Scholar]
  • 49.McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12(1):55–61. doi: 10.1002/jrsm.1411 [DOI] [PubMed] [Google Scholar]
  • 50.Smit M, Olney J, Ford NP, Vitoria M, Gregson S, Vassall A, et al. The growing burden of noncommunicable disease among persons living with HIV in Zimbabwe. AIDS. 2018;32(6):773–82. doi: 10.1097/QAD.0000000000001754 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Mutagonda RF, Siril H, Kaaya S, Amborose T, Haruna T, Mhalu A, et al. Prevalence and determinants of non-communicable diseases including depression among HIV patients on antiretroviral therapy in Dar es Salaam, Tanzania. Trop Med Int Health. 2022;27(8):742–51. doi: 10.1111/tmi.13790 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Tomita A, Leyna GH, Kim H-Y, Moodley Y, Mpolya E, Mogeni P, et al. Patterns of multimorbidity and their association with hospitalisation: a population-based study of older adults in urban Tanzania. Age Ageing. 2021;50(4):1349–60. doi: 10.1093/ageing/afab046 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Mendenhall E, Bosire EN, Kim AW, Norris SA. Cancer, chemotherapy, and HIV: living with cancer amidst comorbidity in a South African township. Soc Sci Med. 2019;237:112461. doi: 10.1016/j.socscimed.2019.112461 [DOI] [PubMed] [Google Scholar]
  • 54.Magafu MGMD, Moji K, Igumbor EU, Magafu NS, Mwandri M, Mwita JC, et al. Non-communicable diseases in antiretroviral therapy recipients in Kagera Tanzania: a cross-sectional study. Pan Afr Med J. 2013;16:84. doi: 10.11604/pamj.2013.16.84.2831 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Calderwood CJ, Marambire E, Nzvere FP, Larsson LS, Chingono RMS, Kavenga F, et al. Prevalence of chronic conditions and multimorbidity among healthcare workers in Zimbabwe: results from a screening intervention. PLOS Glob Public Health. 2024;4(1):e0002630. doi: 10.1371/journal.pgph.0002630 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Qubekile Y, Paruk S, Paruk F. Prevalence of depressive symptoms and quality of life among patients with diabetes mellitus with and without HIV infection: a South African study. S Afr J Psychiatr. 2022;28:1762. doi: 10.4102/sajpsychiatry.v28i0.1762 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Gooden TE, Mkhoi ML, Mdoe M, Mwalukunga LJ, Senkoro E, Kibusi SM, et al. Barriers and facilitators of people living with HIV receiving optimal care for hypertension and diabetes in Tanzania: a qualitative study with healthcare professionals and people living with HIV. BMC Public Health. 2023;23(1):2235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Biraguma J, Mutimura E, Frantz JM. Health-related quality of life and associated factors in adults living with HIV in Rwanda. SAHARA J. 2018;15(1):110–20. doi: 10.1080/17290376.2018.1520144 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Joo JY. Fragmented care and chronic illness patient outcomes: a systematic review. Nurs Open. 2023;10(6):3460–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Mendenhall E, Omondi GB, Bosire E, Isaiah G, Musau A, Ndetei D, et al. Stress, diabetes, and infection: Syndemic suffering at an urban Kenyan hospital. Soc Sci Med. 2015;146:11–20. doi: 10.1016/j.socscimed.2015.10.015 [DOI] [PubMed] [Google Scholar]
  • 61.Akugizibwe M, Zalwango F, Namulundu CM, Namakoola I, Birungi J, Okebe J, et al. “After all, we are all sick”: multi-stakeholder understanding of stigma associated with integrated management of HIV, diabetes and hypertension at selected government clinics in Uganda. BMC Health Serv Res. 2023;23(1):20. doi: 10.1186/s12913-022-08959-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Carpenter B, Nyirenda M, Hanass-Hancock J. Disability, a priority area for health research in South Africa: an analysis of the burden of disease study 2017. Disabil Rehabil. 2022;44(25):7839–47. doi: 10.1080/09638288.2021.2000047 [DOI] [PubMed] [Google Scholar]
  • 63.Adedimeji A, Ajeh R, Pierz A, Nkeng R, Ndenkeh JJ, Fuhngwa N, et al. Challenges and opportunities associated with cervical cancer screening programs in a low income, high HIV prevalence context. BMC Womens Health. 2021;21(1):74. doi: 10.1186/s12905-021-01211-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Bhana A, Rathod SD, Selohilwe O, Kathree T, Petersen I. Characteristics and correlates of alcohol consumption among adult chronic care patients in North West Province, South Africa. S Afr Med J. 2017;107(7):636–42. doi: 10.7196/SAMJ.2017.v107i7.12131 [DOI] [PubMed] [Google Scholar]
  • 65.Jere J, Ruark A, Bidwell JT, Butterfield RM, Neilands TB, Weiser SD, et al. “High blood pressure comes from thinking too much”: understandings of illness among couples living with cardiometabolic disorders and HIV in Malawi. PLoS One. 2023;18(12):e0296473. doi: 10.1371/journal.pone.0296473 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Chang AY, Gómez-Olivé FX, Manne-Goehler J, Wade AN, Tollman S, Gaziano TA, et al. Multimorbidity and care for hypertension, diabetes and HIV among older adults in rural South Africa. Bull World Health Organ. 2019;97(1):10–23. doi: 10.2471/BLT.18.217000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.ABANTU for development. [cited 2025 Feb 20]. Available from: https://abanturowa.org
  • 68.StrongMinds. [cited 2025 Feb 20] Available from: https://strongminds.org
  • 69.Abdulai MA, Marable JK, Wadus A, Asante KP. A qualitative analysis of factors influencing health-seeking behavior of people living with HIV, hypertension and diabetes in an urban area of Ghana. J Multimorb Comorb. 2022;12:26335565221092664. doi: 10.1177/26335565221092664 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Kamkuemah M, Gausi B, Oni T. Missed opportunities for NCD multimorbidity prevention in adolescents and youth living with HIV in urban South Africa. BMC Public Health. 2020;20(1):821. doi: 10.1186/s12889-020-08921-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.HIV life expectancy: aging with HIV. HIV.Gov; n.d. [cited 2024 Nov 22]. Available from: https://www.hiv.gov/hiv-basics/living-well-with-hiv/taking-care-of-yourself/aging-with-hiv [Google Scholar]
  • 72.Partners in health. [cited 2025 Feb 20]. Available from: https://www.pih.org/country/malawi
  • 73.Tanzania Network of Women Living with HIV and AIDS. [cited 2025 Feb 20]. Available from: https://www.tzpositivewomen.or.tz/
  • 74.Zvandiri. [cited 2025 Feb 20]. Available from: https://zvandiri.org
  • 75.Mudra Rakshasa-Loots A. Depression and HIV: a scoping review in search of neuroimmune biomarkers. Brain Commun. 2023;5(5):fcad231. doi: 10.1093/braincomms/fcad231 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Innes S, Patel K. Noncommunicable diseases in adolescents with perinatally acquired HIV-1 infection in high-income and low-income settings. Curr Opin HIV AIDS. 2018;13(3):187–95. doi: 10.1097/COH.0000000000000458 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Saima Hirani

22 May 2025

PONE-D-25-11960Syndemic Interactions between HIV/AIDS, Mental Health Conditions, and Non-Communicable Diseases in sub-Saharan Africa: A Scoping Review of Contributing FactorsPLOS ONE

Dear Dr. Karbasi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Overall, a well-written manuscript with a strong rationale and clear methodology. There are a few areas that require clarity and further details:

  • Is there any target population for this review- any specific age, gender etc.? Please clarify. It would be nice to add the names of African countries to the inclusion criteria.

  • In figure 2, please recheck the calculation- studies screened (2913) - studies excluded (2706) = 207. The total shown in the figure is 188.

  • Scoping reviews do not typically assess the quality of the studies. Usually systematic reviews appraise studies as one of the core components of their methodology. Figure 6 shows the quality assessment of 13 studies. How about other studies’ findings (for quality)?

It would be nice to add a discussion around age distribution in the current evidence. Highlighting any gaps would be useful for future research.

Please submit your revised manuscript by Jul 06 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Saima Hirani, PhD

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please amend either the abstract on the online submission form (via Edit Submission) or the abstract in the manuscript so that they are identical. 3. We note that Figure 3 in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or remove the figures from your submission: a. You may seek permission from the original copyright holder of Figure 3 to publish the content specifically under the CC BY 4.0 license.   We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.The following resources for replacing copyrighted map figures may be helpful: USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.htmlNASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/Landsat: http://landsat.visibleearth.nasa.gov/USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#Natural Earth (public domain): http://www.naturalearthdata.com/ 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Please find the Reviewers' comments below.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1:  Line 492- 493: Will the figures be expanded in the final print? The legends in the current format are not legible

Line 501: It was nice that the author used the phrase ‘synthesize current evidence’ as another study conducted by Moyo-Chilufya et al. 2023 considered NCD and mental disorders among PLHIV in Africa (ref: https://pmc.ncbi.nlm.nih.gov/articles/PMC10570719/).

Line 574: ‘As the population ages and the prevalence of NCDs rises’, kindly provide a reference for the statement.

Reviewer #2:  In this scoping review, the authors explored existing evidence on the relationship between HIV, mental health issues, and non-communicable co-morbidities such as hypertension and diabetes. The review is interesting and well-written. This is not usually the case for me as a reviewer, but I have almost no substantive comments for the authors. The review is contextualised appropriately, the methods are described adequately, the results seem reliable and interesting, and the discussion is reasonable without being overly ambitious. Well done!

My only suggestion would be to include a discussion of the lack of children or adolescents living with HIV in these studies. All the studies included in the review enrolled people above 18 years of age, and many were much older. Children and young people living with HIV tend to be neglected in research, especially mental health research. For a starting point for discussion of this, see the section on “insights in absence” in DOI: 10.1093/braincomms/fcad231 which also found that children and young people were absent in research on depression/inflammation. I appreciate that many of the non-communicable diseases that were of interest to the authors are more prevalent in older adults – though this is not always the case (e.g. Type 1 diabetes or chronic respiratory issues can be of substantial impact in young people), so it’s still important to highlight the lack of evidence in children with HIV.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2025 Aug 21;20(8):e0328515. doi: 10.1371/journal.pone.0328515.r002

Author response to Decision Letter 1


12 Jun 2025

We would like to express our sincere gratitude to the reviewers and the editorial team for their careful and thorough review of our manuscript. We greatly appreciate the time, effort, and expertise that went into evaluating our work. In the sections below, we provide detailed, point-by-point responses to each of the editorial and reviewer comments. We have carefully considered all feedback and have revised the manuscript accordingly to address the concerns and suggestions raised.

We are especially thankful for the opportunity to revise and resubmit our manuscript. The constructive critiques we received have been instrumental in enhancing the clarity, rigor, and overall quality of the paper. We believe that the manuscript is now substantially improved and hope that the revisions meet your expectations.

Comments from the Editor

Editor Comment 1

1. Is there any target population for this review-any specific age, gender, etc.? Please clarify. It would be nice to add the names of African Countries to the inclusion criteria.

Author Response to Comment 1: Thank you for your thoughtful suggestions. In designing our selection criteria, we intentionally did not impose any specific age or gender restrictions during the selection process, as our aim was to ensure the review was as inclusive and representative of the current literature as possible. By including studies across all age groups and genders, we aimed to ensure that our analysis reflects the diverse and multifaceted nature of syndemic interactions. We specifically sought to examine contributing factors relevant to both male and female individuals to reflect the broader landscape of syndemic interactions.

While all included studies enrolled participants aged 18 and older—with the exception of Carpenter et al.—we did not apply an upper or lower age limit in our inclusion criteria. As noted in Section 2.1 (Inclusion/Exclusion Criteria), we have incorporated a note indicating no restrictions were placed on age or gender. Interestingly, the absence of studies involving children and adolescents highlights a clear gap in the current literature. We have now addressed this point explicitly in the lack of syndemic literature section, emphasizing the need for future research focused on younger populations, who appear to be underrepresented in syndemics research despite the potential relevance of several non-communicable conditions in this group.

Regarding your second point, given the large number of countries represented in the included studies (approximately 46), we opted to avoid listing them all in the main text to reduce visual clutter. Instead, we have provided the full list of countries in S1 Appendix SS for reference.

Editor Comment 2

2. In Figure 2, please recheck the calculation—the studies screened (2913) – studies excluded (2706) = 207. The total shown in the figure is 188.

Author Response to Comment 2: Thank you for carefully reviewing the figure and bringing this discrepancy to our attention. We have rechecked the calculations and identified the source of the error. The figure has been revised accordingly to accurately reflect the correct number of studies. The updated version is now included in the revised manuscript.

Editor Comment 3

3. Scoping reviews do not typically assess the quality of the studies. Usually, systematic reviews appraise studies as one of the core components of their methodology. Figure 6 shows the quality assessment of 13 studies. How about other studies’ findings (for quality)?

Author Response to Comment 3: Thank you for the observation. You are correct that formal quality or risk of bias (RoB) assessments are not typically required for scoping reviews, as the primary goal is to map the breadth of evidence rather than evaluate the strength of individual findings. In our case, we conducted a targeted quality assessment of the 13 studies most directly aligned (i.e., qualitative, mixed methods, and cross-sectional) with our objective to provide insight into the methodological rigor of this subset. While we did review all included studies qualitatively for relevance and basic methodological soundness, we did not apply a formal RoB tool to the remaining studies (4), consistent with scoping review methodology. We have clarified this in the manuscript in section 3.6 Quality assessment and specified the quality assessment presented in Figure 6.

Comments from Reviewers

Reviewer 1 Comment 1

1. Line 492-493: Will the figures be expanded in the final print? The legends in the current format are not legible.

Author Response to Comment 1: Thank you for this helpful observation. We agree that clarity is essential for effective communication of the data. In response, we have revised the figure by enlarging the legend to improve legibility and ensure that all elements are clearly visible. The updated figure has been included in the revised manuscript.

Reviewer 1 Comment 2

2. Line 501: it was nice that the author used the phrase ‘synthesize current evidence’ as another study conducted by Moyo-Chilufya et al. 2023 considered NCD and mental disorders among PLHIV in Africa.

Author Response to Comment 2: Thank you for your kind words and for highlighting the relevance of the phrase in connection with the work by Moyo-Chilufya et al. (2023). We appreciate your recognition and are encouraged by the alignment of our approach with existing research in this important area.

Reviewer 1 Comment 3

3. Line 574: ‘As the population ages and the prevalence of NCDs rises’, kindly provide a reference for this statement.

Author Response to Comment 3: Thank you for catching this important detail. We have now added appropriate references to support this statement, drawing from recent literature that highlights the global trends in aging populations and the increasing burden of NCDs. These citations have been included in the revised manuscript to strengthen the contextual foundation of this point.

Reviewer 2 Comment 1

1. In this scoping review, the authors explored existing evidence on the relationship between HIV, mental health issues, and non-communicable co-morbidities such as hypertension and diabetes, The review is interesting and well-written. This not usually the case for me as a reviewer, but I have almost not substantive comments for the authors. The review is contextualized appropriately, the methods are described adequately, the results seem reliable and interesting, and the discussion is reasonable without being overly ambitious. Well done!

My only suggestion would be to include a discussion of the lack of children or adolescents living with HIV in these studies. All the studies included in the review enrolled people above 18 years of age, and many were much older. Children and young people living with HIV tend to be neglected in research, especially mental health research. For a starting point for discussion of this, see the section on “insights in absence” in DOI:10.1093/braincomms/fcad231 which also found that children and young people were absent in research on depression/inflammation. I appreciate that many of the non-communicable diseases that were of interest to the authors are more prevalent in older adults – though this is not always the case (e.g. Type I diabetes and chronic respiratory issues can be of substantial impact in young people), so it’s still important to highlight the lack of evidence in children with HIV.

Author Response to Comment 1: Thank you very much for your generous feedback and for highlighting an important gap in the literature. We greatly appreciate your thoughtful suggestion regarding the exclusion of children and adolescents living with HIV in the studies reviewed. In response we have expanded Section 4.1, to explicitly address this issue by discussing the lack of syndemic research involving younger populations living with HIV in Africa. We have also cited the article you recommended (DOI:10.1093/braincomms/fcad231) to underscore the broader concern of underrepresentation of children and adolescents in mental health and syndemic research. We agree that this is a critical area for future investigation, particularly given the unique challenges faced by younger individuals with chronic conditions such as HIV and NCDs.

Attachment

Submitted filename: Response to Reviewers.docx

pone.0328515.s004.docx (20.8KB, docx)

Decision Letter 1

Saima Hirani

20 Jun 2025

PONE-D-25-11960R1Syndemic Interactions between HIV/AIDS, Mental Health Conditions, and Non-Communicable Diseases in sub-Saharan Africa: A Scoping Review of Contributing FactorsPLOS ONE

Dear Dr. Karbasi,

Thank you for submitting your revised manuscript to PLOS ONE. We appreciate the time and effort you have put into addressing the reviewers' comments. After reviewing the updated submission, we noted that while many of the comments have been addressed thoughtfully, there are still a few points that require further attention before we can proceed. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Kindly review Figure 2 (the PRISMA flow diagram) carefully to ensure that the number of studies is accurately represented throughout the chart.

Please submit your revised manuscript by Aug 04 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Saima Hirani, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2025 Aug 21;20(8):e0328515. doi: 10.1371/journal.pone.0328515.r004

Author response to Decision Letter 2


23 Jun 2025

We have corrected PRISMA Flow Diagram to account for the correct number of studies and appreciate the editor for bringing this to our attention.

Attachment

Submitted filename: Response to Reviewers 2.docx

pone.0328515.s005.docx (16.2KB, docx)

Decision Letter 2

Saima Hirani

3 Jul 2025

Syndemic Interactions between HIV/AIDS, Mental Health Conditions, and Non-Communicable Diseases in sub-Saharan Africa: A Scoping Review of Contributing Factors

PONE-D-25-11960R2

Dear Dr. Karbasi,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Saima Hirani, PhD

Academic Editor

PLOS ONE

Acceptance letter

Saima Hirani

PONE-D-25-11960R2

PLOS ONE

Dear Dr. Karbasi,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Saima Hirani

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Appendix. Search strategy.

    For our search strategy, the search items included: Non-communicable Diseases (i.e., Cardiovascular Disease, Cancer, Kidney Disease, Respiratory Diseases, and Diabetes), Mental Health (i.e., Mood disorders, substance-use disorders, anxiety disorders, Stigma), and People living with HIV. The search limits included the following: publication year of 2000–2024, no language restrictions, geography of Sub-saharan Africa, and studies focusing specifically on examining the impact of HIV and mental health on the prevalence and management of Non-communicable Diseases.

    (DOCX)

    pone.0328515.s001.docx (36.8KB, docx)
    S2 Appendix. PRISMA-ScR-Checklist.

    Illustrates the selection procedure for studies including in this scoping review. Additionally, it follows the PRISMA Scoping Review guidelines.

    (PDF)

    pone.0328515.s002.pdf (644.7KB, pdf)
    S3 Appendix. Multi-morbidity trends among people living with HIV.

    Demonstrates the prevalence of multi-morbidities across sex and age groups among PLWH (Panel A), and the proportion of individuals with two or more NCDs in 2015 and projected for 2035 (Panel B). Provides a demographic insight into the changing burden of NCDs over time.

    (XLSX)

    pone.0328515.s003.xlsx (9.7KB, xlsx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0328515.s004.docx (20.8KB, docx)
    Attachment

    Submitted filename: Response to Reviewers 2.docx

    pone.0328515.s005.docx (16.2KB, docx)

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES